InBody Co., Ltd.

041830KOSDAQMedical, precision and optical instruments

InBody Co., Ltd. (041830, KOSDAQ) reported KRW 234bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
20231703837274250Consolidated
20242043733306274Consolidated
20252343730361320Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
202322.5%21.5%91%14.6%
202418%16%89.6%11.9%
202515.7%12.8%88.6%9.4%

Revenue moved 37.3% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 789bn
Close priceKRW 58,500
Listed shares13,480,882
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)370
Women137 (37%)
Average tenure4.5 years
Annual pay, menKRW 55,000,000
Annual pay, womenKRW 49,000,000
Pay ratio, women to men89.1%

Other companies in Medical, precision and optical instruments

102 listed companies file under this classification. Showing 12.

See the whole Medical, precision and optical instruments list →